Can frequent CRP checks prevent relapses in giant cell arteritis?
NCT ID NCT07720804
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This pilot study is investigating how quickly C-reactive protein (CRP), a key marker of inflammation, drops after starting steroid treatment in people newly diagnosed with giant cell arteritis. By measuring CRP levels daily, then weekly and monthly for up to a year, researchers hope to understand how CRP changes relate to symptoms and whether early normalization could guide treatment adjustments to avoid complications or relapses. The study involves 40 adults hospitalized with a new diagnosis of giant cell arteritis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- blood tests to measure C-reactive protein (CRP) levels
- What this could lead to
- If successful, this could help doctors personalize steroid dosing for giant cell arteritis, potentially reducing complications and relapses.
- What could go wrong
- This is a small pilot study with only 40 participants, so findings may not apply to all patients. It is observational and does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS (GCA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ultrasound clue vanishes days after steroids start in artery disease
- New Total-Body PET scanner could revolutionize vasculitis diagnosis
- New drug combo aims to tame blood vessel inflammation
- Could 8 weeks of steroids be enough? new trial aims to cut treatment time for GCA
- New ultrasound method could predict relapses in rare artery disease
- Which drug protects the heart better in giant cell arteritis?